TELA Bio
TELA
44 hedge funds and large institutions have $161M invested in TELA Bio in 2020 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 16 increasing their positions, 15 reducing their positions, and 11 closing their positions.
28% more capital invested
Capital invested by funds: $126M → $161M (+$35.1M)
7% more repeat investments, than reductions
Existing positions increased: 16 | Existing positions reduced: 15
0.12% more ownership
Funds ownership: 67.56% → 67.68% (+0.12%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
10% less funds holding
Funds holding: 49 → 44 (-5)
45% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 11
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PVI
Pura Vida Investments
New York
|
+$4.05M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$2.34M |
| 3 |
AC
Armistice Capital
New York
|
+$2.25M |
| 4 |
OM
Opaleye Management
Boston,
Massachusetts
|
+$1.57M |
| 5 |
EWM
Essex Woodlands Management
The Woodlands,
Texas
|
+$1.17M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Alyeska Investment Group
Chicago,
Illinois
|
-$3.7M |
| 2 |
LM
Luminus Management
Houston,
Texas
|
-$2.45M |
| 3 |
CH
CVI Holdings
Wilmington,
Delaware
|
-$1.47M |
| 4 |
SMH
Sanders Morris Harris
Houston,
Texas
|
-$1.42M |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$809K |
TELA Hedge Fund Activity: Q3 2020 in Review
44 of the 4,957 institutional investors tracked by Wall St. Rank reported a position in TELA Bio (TELA) for Q3 2020, worth a combined $161M — up 28% from $126M a quarter earlier.
Sellers outnumbered buyers: 11 funds closed out of TELA and 6 opened new positions — a net loss of 5 holders — while 15 trimmed existing stakes and 16 added.
The largest buyer was Pura Vida Investments, opening a new position worth an estimated $4.05M. The largest seller was Alyeska Investment Group, cutting an estimated $3.7M.
- 44 institutional investors held TELA Bio (TELA) as of Q3 2020, down from 49 in Q2 2020.
- Funds reported $161M of TELA Bio stock for Q3 2020, up 28% quarter-over-quarter.
- 6 funds opened new TELA Bio positions in Q3 2020 and 11 closed out, a net change of -5 holders.
- The largest TELA Bio buyer in Q3 2020 was Pura Vida Investments, an estimated $4.05M added.
- The largest TELA Bio seller in Q3 2020 was Alyeska Investment Group, an estimated $3.7M sold.
Based on aggregated 13F filings for Q3 2020.